Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up

被引:68
作者
Taghizadeh, Niloofar [1 ,2 ]
Vonk, Judith M. [1 ,3 ]
Boezen, H. Marike [1 ,3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[2] Univ Calgary, Cumming Sch Med, Div Resp Med, Calgary, AB, Canada
[3] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
NEGATIVE EXPONENTIAL MODEL; ALL-CAUSE MORTALITY; BREAST-CANCER RISK; CIGARETTE-SMOKING; LUNG-CANCER; EPIDEMIOLOGIC EVIDENCE; QUITTING SMOKING; PIPE SMOKING; WOMEN; DISEASE;
D O I
10.1371/journal.pone.0153310
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background In general, smoking increases the risk of mortality. However, it is less clear how the relative risk varies by cause of death. The exact impact of changes in smoking habits throughout life on different mortality risks is less studied. Methods We studied the impact of baseline and lifetime smoking habits, and duration of smoking on the risk of all-cause mortality, mortality of cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), any cancer and of the four most common types of cancer (lung, colorectal, prostate, and breast cancer) in a cohort study (Vlagtwedde-Vlaardingen 1965-1990, with a follow-up on mortality status until 2009, n = 8,645). We used Cox regression models adjusted for age, BMI, sex, and place of residence. Since previous studies suggested a potential effect modification of sex, we additionally stratified by sex and tested for interactions. In addition, to determine which cause of death carried the highest risk we performed competing-risk analyses on mortality due to CVD, cancer, COPD and other causes. Results Current smoking (light, moderate, and heavy cigarette smoking) and lifetime persistent smoking were associated with an increased risk of all-cause, CVD, COPD, any cancer, and lung cancer mortality. Higher numbers of pack years at baseline were associated with an increased risk of all-cause, CVD, COPD, any cancer, lung, colorectal, and prostate cancer mortality. Males who were lifetime persistent pipe/cigar smokers had a higher risk of lung cancer [HR (95% CI) = 7.72 (1.72-34.75)] as well as all-cause and any cancer mortality. A longer duration of smoking was associated with a higher risk of COPD, any and lung cancer [HR (95% CI) = 1.06 (1.00-1.12), 1.03 (1.00-1.06) and 1.10 (1.03-1.17) respectively], but not with other mortality causes. The competing risk analyses showed that ex-and current smokers had a higher risk of cancer, CVD, and COPD mortality compared to all other mortality causes. In addition, heavy smokers had a higher risk for COPD mortality compared to cancer, and CVD mortality. Conclusion Our study indicates that lifetime numbers of cigarettes smoked and the duration of smoking have different impacts for different causes of mortality. Moreover, our findings emphasize the importance of smoking-related competing risks when studying the smoking-related cancer mortality in a general population and that smoking cessation immediately effectively reduces the risk of all-cause and any cancer mortality.
引用
收藏
页数:18
相关论文
共 39 条
  • [1] Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study
    Agudo, Antonio
    Bonet, Catalina
    Travier, Noemie
    Gonzalez, Carlos A.
    Vineis, Paolo
    Bueno-de-Mesquita, H. Bas
    Trichopoulos, Dimitrios
    Boffetta, Paolo
    Clavel-Chapelon, Francoise
    Boutron-Ruault, Marie-Christine
    Kaaks, Rudolf
    Lukanova, Annekatrin
    Schuetze, Madlen
    Boeing, Heiner
    Tjonneland, Anne
    Halkjaer, Jytte
    Overvad, Kim
    Dahm, Christina C.
    Ramon Quiros, J.
    Sanchez, Maria-Jose
    Larranaga, Nerea
    Navarro, Carmen
    Ardanaz, Eva
    Khaw, Kay-Tee
    Wareham, Nicholas J.
    Key, Timothy J.
    Allen, Naomi E.
    Trichopoulou, Antonia
    Lagiou, Pagona
    Palli, Domenico
    Sieri, Sabina
    Tumino, Rosario
    Panico, Salvatore
    Boshuizen, Hendriek
    Buchner, Frederike L.
    Peeters, Petra H. M.
    Borgquist, Signe
    Almquist, Martin
    Hallmans, Goran
    Johansson, Ingegerd
    Gram, Inger T.
    Lund, Eiliv
    Weiderpass, Elisabete
    Romieu, Isabelle
    Riboli, Elio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) : 4550 - 4557
  • [2] [Anonymous], 1986, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, V38, P37
  • [3] [Anonymous], 2011, WHO I Global atlas on cardiovascular disease prevention and control
  • [4] [Anonymous], 2012, World Health Report
  • [5] Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review
    Athyros, Vassilios G.
    Katsiki, Niki
    Doumas, Michael
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (10) : 1263 - 1274
  • [6] THE ANTIESTROGENIC EFFECT OF CIGARETTE-SMOKING IN WOMEN
    BARON, JA
    LAVECCHIA, C
    LEVI, F
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (02) : 502 - 514
  • [7] Alcohol, tobacco and breast cancer -: collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease
    Beral, V
    Hamajima, N
    Hirose, K
    Rohan, T
    Calle, EE
    Heath, CW
    Coates, RJ
    Liff, JM
    Talamini, R
    Chantarakul, N
    Koetsawang, S
    Rachawat, D
    Morabia, A
    Schuman, L
    Stewart, W
    Szklo, M
    Bain, C
    Schofield, F
    Siskind, V
    Band, P
    Coldman, AJ
    Gallagher, RP
    Hislop, TG
    Yang, P
    Kolonel, LM
    Nomura, AMY
    Hu, J
    Johnson, KC
    Mao, Y
    De Sanjose, S
    Lee, N
    Marchbanks, P
    Ory, HW
    Peterson, HB
    Wilson, HG
    Wingo, PA
    Ebeling, K
    Kunde, D
    Nishan, P
    Hopper, JL
    Colditz, G
    Gajalakshmi, V
    Martin, N
    Pardthaisong, T
    Solpisornkosol, S
    Theetranont, C
    Boosiri, B
    Chutivongse, S
    Jimakorn, P
    Virutamasen, P
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (11) : 1234 - 1245
  • [8] Molecular Signature of Smoking in Human Lung Tissues
    Bosse, Yohan
    Postma, Dirkje S.
    Sin, Don D.
    Lamontagne, Maxime
    Couture, Christian
    Gaudreault, Nathalie
    Joubert, Philippe
    Wong, Vivien
    Elliott, Mark
    van den Berge, Maarten
    Brandsma, Corry A.
    Tribouley, Catherine
    Malkov, Vladislav
    Tsou, Jeffrey A.
    Opiteck, Gregory J.
    Hogg, James C.
    Sandford, Andrew J.
    Timens, Wim
    Pare, Peter D.
    Laviolette, Michel
    [J]. CANCER RESEARCH, 2012, 72 (15) : 3753 - 3763
  • [9] Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review
    Braithwaite, Dejana
    Izano, Monika
    Moore, Dan H.
    Kwan, Marilyn L.
    Tammemagi, Martin C.
    Hiatt, Robert A.
    Kerlikowske, Karla
    Kroenke, Candyce H.
    Sweeney, Carol
    Habel, Laurel
    Castillo, Adrienne
    Weltzien, Erin
    Caan, Bette
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (02) : 521 - 533
  • [10] Smoking and Mortality - Beyond Established Causes
    Carter, Brian D.
    Abnet, Christian C.
    Feskanich, Diane
    Freedman, Neal D.
    Hartge, Patricia
    Lewis, Cora E.
    Ockene, Judith K.
    Prentice, Ross L.
    Speizer, Frank E.
    Thun, Michael J.
    Jacobs, Eric J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07) : 631 - 640